MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
HER2/EGFR in Cancer Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,303 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,303 works in the cohort · of 4,299,418page 1 of 27

Labels cover 3 of 1,303 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,303 of 1,303 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni, Ian E. Krop, Manfred Welslau, José Baselga +8 more
2012· article· en· New England Journal of Medicine· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
3,784
citations
affunlabeled
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press +17 more
2011· article· en· New England Journal of Medicine· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
2,775
citations
affunlabeled
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira +24 more
2021· article· en· New England Journal of Medicine· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
1,543
citations
affunlabeled
Antibody–Drug Conjugates: A Comprehensive Review
Puregmaa Khongorzul, Cai Ling, Farhan Ullah Khan, Awais Ullah Ihsan, Juan Zhang
2019· review· en· Molecular Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · insufficient_payload
770
citations
affno abstractunlabeled
HER2 testing in gastric cancer: a practical approach
Josef Rüschoff, Wedad Hanna, Michael Bilous, Manfred Hofmann, R. Yoshiyuki Osamura, Frédérique Penault‐Llorca +2 more
2012· article· en· Modern Pathology· Medicine
distilled prediction:candidate · noneconsensus · none
596
citations
fundno affno abstractunlabeled
Architecture and Membrane Interactions of the EGF Receptor
Anton Arkhipov, Yibing Shan, Rahul Das, Nicholas Endres, Michael P. Eastwood, David E. Wemmer +2 more
2013· article· en· Cell· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
525
citations
affunlabeled
Breast Cancer Treatments: Updates and New Challenges
Anna Burguin, Caroline Diorio, Francine Durocher
2021· review· en· Journal of Personalized Medicine· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
473
citations
afffundno abstractunlabeled
ErbB Receptors and Cancer
Zhixiang Wang
2017· review· en· Methods in molecular biology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
431
citations
affno abstractunlabeled
Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer
Andreas Schneeweiß, Stephen Chia, Tamas Hickish, Vernon Harvey, Alexandru Eniu, Maeve Waldron-Lynch +3 more
2017· article· en· European Journal of Cancer· Medicine
distilled prediction:candidate · noneconsensus · none
283
citations
affunlabeled
Updated UK Recommendations for HER2 assessment in breast cancer
Emad A. Rakha, Sarah E. Pinder, John M.S. Bartlett, Merdol Ibrahim, Jane Starczynski, P J Carder +5 more
2014· article· en· Journal of Clinical Pathology· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
259
citations
affunlabeled
Luminal-B breast cancer and novel therapeutic targets
Ben Tran, Philippe L. Bédard
2011· review· en· Breast Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
249
citations
affunlabeled
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
Angela N. Bartley, M. Kay Washington, Christina B. Ventura, Nofisat Ismaila, Carol Colasacco, Al B. Benson +9 more
2016· article· en· Archives of Pathology & Laboratory Medicine· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+stsconsensus · none
246
citations
afffundunlabeled
Breast cancer — one term, many entities?
Nicholas Bertos, Morag Park
2011· review· en· Journal of Clinical Investigation· Medicine
distilled prediction:candidate · research_integrity+insufficient_payloadconsensus · none
230
citations
fundno affno abstractunlabeled
Trastuzumab in the Treatment of Breast Cancer
Sofia Maximiano, Paulo Magalhães, Mara Pereira Guerreiro, Manuel Morgado
2016· review· en· BioDrugs· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
230
citations

How this was built: Screen · Findings · About